Transitional Cell Carcinoma of the Urothelium
📧 Sign up to get email alerts when something new happens for Transitional Cell Carcinoma of the Urothelium.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-11-25Clinical Trial Update: Everolimus (RAD001) in Metastatic Transitional Cell Carcinoma of the Urothelium [Phase 2]
Phase 2 clinical trial update for Everolimus (RAD001) in metastatic transitional cell carcinoma of the urothelium (bladder cancer) completed…
-
CLINICAL_TRIALS trial_result · 2021-06-21Clinical Trial Update: Buparlisib in Metastatic Transitional Cell Carcinoma of the Urothelium [Phase 2]
Phase 2 trial update of buparlisib in metastatic transitional cell carcinoma of the urothelium completed with posted results.
-
CLINICAL_TRIALS trial_result · 2018-10-26Clinical Trial Update: Gemcitabine Hydrochloride, Cisplatin, and Sunitinib Malate as First-Line Therapy in Treating Patients With Locally Advanced And/or Metastatic Transitional Cell Carcinoma of the Urothelium (SUCCINCT) [Phase 2]
Phase 2 trial evaluating first-line gemcitabine hydrochloride, cisplatin, and sunitinib malate for locally advanced or metastatic transition…
-
CLINICAL_TRIALS trial_result · 2016-06-21Clinical Trial Update: The Efficacy of RAD 001 as Second Line Therapy in Patients With Transitional Cell Carcinoma TCC of the Urothelium [Phase 2]
This Phase 2 trial evaluates RAD 001 (everolimus) as second-line therapy for urothelial cancer (transitional cell carcinoma of the urotheliu…